Verification Opinions of the Remuneration and Assessment Committee on the Repurchase and Cancellation of Certain Restricted Stocks from the 2023 Incentive Plan

✨ AI Summary

The Remuneration and Assessment Committee of Xiamen Aide Biological Pharmaceutical Technology Co., Ltd. approved the repurchase and cancellation of 1,430,975 restricted stocks due to 29 individuals no longer qualifying as incentive targets. The repurchase price is set at 11.32 yuan per share plus bank interest. This decision complies with relevant regulations and will not adversely affect the company's financial status or shareholder interests.

Summary generated by AI · Always verify with source document